Control and Reward Circuits in Obsessive Compulsive Disorder
- Conditions
- Obsessive-Compulsive Disorder
- Interventions
- Behavioral: Exposure & Response Prevention (EX/RP)
- Registration Number
- NCT02221518
- Lead Sponsor
- New York State Psychiatric Institute
- Brief Summary
The purpose of this study is to examine the brain functioning of OCD patients and healthy controls before and after treatment with Exposure and Response Prevention (EXRP) therapy.
- Detailed Description
The capacity to coordinate thoughts and actions to execute goal-directed behaviors (cognitive control) and the capacity to anticipate, respond to, and learn from reward (reward processing) are key processes for human behavior. Dysfunction in these processes has been hypothesized to contribute to repetitive thoughts and behaviors in many disorders, including obsessive-compulsive disorder (OCD), Tourette Syndrome (TS), and eating disorders. We will use multimodal imaging to investigate neural circuits that support cognitive control and reward processing, using OCD as a model system. The short-term goal is to clarify how circuit-based abnormalities contribute to repetitive thoughts/behaviors; these data will inform future transdiagnostic studies. The long-term goal is to identify control and reward circuit-abnormalities as targets for new transdiagnostic treatments.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Patients with OCD Exposure & Response Prevention (EX/RP) Behavioral: Exposure \& Response Prevention (EX/RP)
- Primary Outcome Measures
Name Time Method Change from baseline in brain activation (fMRI) and fractional anisotropy (Diffusion tensor imaging) after therapy Baseline & approximately 10 weeks later
- Secondary Outcome Measures
Name Time Method Change in reaction times and correct responses on Stop signal reaction time task Baseline and approximately 10 weeks later, at second scan
Trial Locations
- Locations (1)
NY State Psychiatric Institute
🇺🇸New York, New York, United States